Ipamorelin is a growth hormone–releasing peptide studied for its ability to stimulate natural GH pulses with high selectivity and low cortisol impact. Using it correctly requires understanding reconstitution, injection timing, and cycle structure — subject to medical approval by a licensed provider at TelosRX.
Ipamorelin is not FDA-approved for any human indication and is available as a compounded peptide through licensed telehealth providers, subject to provider-issued prescriptions following medical evaluation. This guide covers each step of an evidence-informed ipamorelin protocol, from mechanism to progress tracking. Research on ipamorelin includes clinical work cited in PMC studies on GH secretion and sleep and is indexed across ClinicalTrials.gov.
Step 1: Understand What Ipamorelin Does
Ipamorelin is a synthetic pentapeptide that binds the ghrelin receptor (GHS-R1a) in the pituitary and hypothalamus. Binding triggers a pulse of growth hormone release that closely mirrors your body's natural GH secretion pattern.
Unlike older GHRPs such as GHRP-2 or GHRP-6, ipamorelin was designed for high selectivity. It stimulates GH release without meaningfully raising cortisol or prolactin — two side effects that made earlier secretagogues less desirable for long-term use.
Researchers have studied ipamorelin for effects on:
- Lean body mass and fat metabolism
- Sleep quality and recovery (GH peaks naturally during slow-wave sleep)
- Connective tissue and joint support via IGF-1 signaling
- Energy and general vitality
Understanding what the peptide actually does helps you set realistic expectations before you start. It amplifies your existing GH axis — it doesn't replace it.
Step 2: Get Evaluated by a Licensed Provider
Ipamorelin requires a provider-issued prescription. This isn't a formality — it's the step that makes the protocol medically appropriate for your specific situation.
A proper evaluation covers:
- Baseline labs (IGF-1, metabolic panel, hormones if relevant)
- Current medications and health history
- Goals and timeline
- Contraindications — active malignancy, uncontrolled endocrine conditions, and pregnancy are reasons a provider may advise against GH-modulating peptides
At TelosRX, this process is asynchronous — you complete your intake online, and a licensed provider reviews it on their schedule. There's no live video call required. If approved, your compounded ipamorelin ships directly. Approval is subject to provider discretion and is not guaranteed.
If you're exploring the peptide stack context, see our overview of CJC-1295 and Ipamorelin together — ipamorelin alone (as a GHRP) and paired with CJC-1295 (a GHRH analog) represent different protocol approaches your provider can guide you on.
Step 3: Reconstitute Your Ipamorelin Vial
Compounded ipamorelin arrives lyophilized — a fine powder in a sealed vial. You mix it with bacteriostatic water (BAC water) before use. This step is where most errors happen.
- Gather supplies — ipamorelin vial, BAC water, insulin syringes (U-100), alcohol swabs.
- Swab both vial stoppers with an alcohol pad. Let them air-dry 30 seconds.
- Draw BAC water into a syringe per your provider's instructions (typically 1–2 mL per vial depending on vial size).
- Inject BAC water slowly into the ipamorelin vial, directing the stream down the glass side rather than onto the powder directly.
- Gently swirl — do not shake. Shaking can degrade the peptide. The solution should become clear within 30–60 seconds.
- Inspect the solution — it should be clear and colorless. Discard if cloudy, particulate, or discolored.
Store the reconstituted vial refrigerated at 36–46°F. Use within the timeframe specified by your compounding pharmacy (typically 28–30 days once mixed).
Step 4: Calculate Your Dose
Your provider sets your dose. The numbers below are for educational reference only — never dose without provider guidance.
| Common Research Range | Frequency | Typical Context |
|---|---|---|
| 100 mcg | Once daily (night) | Entry-level, sleep/recovery focus |
| 100–200 mcg | Twice daily | Body composition and recovery |
| 200–300 mcg | Once to twice daily | Higher-intensity protocols, provider-supervised |
To convert your dose to syringe units: divide your target dose (in mcg) by the concentration in your vial (mcg/mL). If your provider prescribed 100 mcg and your vial is reconstituted to 500 mcg/mL, you draw 0.2 mL (20 units on a U-100 syringe). Always confirm the math with your provider or pharmacy.
Step 5: Inject at the Right Time and Site
Timing matters more with ipamorelin than with some other peptides because it works by amplifying GH pulses that already occur naturally.
When to inject: Natural GH release peaks during slow-wave sleep, roughly 60–90 minutes after sleep onset. Injecting 20–30 minutes before bed maximizes alignment with that window. If your protocol includes a daytime dose, fasted morning or pre-workout (separated from meals by at least 90 minutes) is the standard recommendation — food, especially carbohydrates and fat, blunts GH release.
Injection site: Subcutaneous injection — into the fatty tissue of the abdomen, outer thigh, or upper arm. Rotate sites each injection to prevent lipohypertrophy (localized fat change). Use the shortest needle available (typically 8mm or 6mm on an insulin syringe).
Technique in brief: pinch skin, insert at 45–90°, inject slowly, withdraw, apply light pressure.
For context on how sleep timing relates to GH release, see our article on sermorelin and growth hormone peptides — sermorelin acts on the same nocturnal GH pulse timing as ipamorelin.
Step 6: Structure Your Cycle
Most clinical protocols run ipamorelin in cycles to maintain receptor sensitivity and support natural GH axis function.
A standard cycle structure is:
- 8–12 weeks on followed by a 4-week break
- Some providers extend to 16 weeks before a break, especially when tracking IGF-1 labs
- Continuous indefinite use without breaks is not the standard approach in most functional medicine protocols
Stack considerations: Ipamorelin is often paired with CJC-1295 (a GHRH analog) because the two work through complementary receptor pathways — ipamorelin triggers GH pulse amplitude while CJC-1295 extends pulse duration. This combination is sometimes compared to MK-677 (ibutamoren), an oral GH secretagogue. Each has different tradeoffs your provider can weigh for your goals.
If you're on TRT, see also our guide on testosterone replacement therapy — GH peptides and TRT are sometimes used together in comprehensive hormone optimization, always under provider supervision.
Ready to explore ipamorelin or a peptide stack? Start your private evaluation at TelosRX — the async intake takes minutes and a licensed provider reviews it on their schedule.
Step 7: Track Your Progress
Peptide protocols are most useful when outcomes are measurable. Track three things in parallel:
- Subjective markers — sleep quality, morning recovery feeling, energy, exercise performance, body composition changes visible in the mirror. These shift first, often within 2–4 weeks.
- Objective body metrics — weight, body composition (if you have access to DEXA or bioimpedance), strength numbers. Changes in body composition from GH signaling are gradual; expect visible shifts at 8–12 weeks of consistent use alongside training and adequate protein intake.
- Lab markers — IGF-1 is the primary lab your provider will use to monitor GH axis response. Baseline before starting, recheck at 6–8 weeks. Your provider will interpret the numbers in the context of your goals and starting point.
Lifestyle factors amplify or undercut the protocol. Poor sleep, excess alcohol, high-carbohydrate meals close to injection time, and inadequate protein all blunt GH signaling. The peptide works with your physiology — it doesn't override poor inputs.
Frequently Asked Questions
Is ipamorelin FDA-approved?
No. Ipamorelin is not FDA-approved for any human use. It is available as a compounded peptide through licensed providers following a medical evaluation. Compounded ipamorelin is prepared under federal compounding regulations and dispensed by licensed compounding pharmacies.
How long until ipamorelin shows results?
Most people notice improved sleep quality and recovery within 2–4 weeks. Visible changes in body composition — increased lean mass, reduced fat — typically emerge over 8–12 weeks of consistent use alongside proper nutrition and resistance training. GH-related changes are gradual and cumulative.
Can ipamorelin be used alone or does it need CJC-1295?
Ipamorelin works as a standalone GHRP. Pairing it with CJC-1295 (a GHRH analog) amplifies the GH pulse — CJC-1295 extends pulse duration while ipamorelin triggers the pulse amplitude. Whether to use ipamorelin alone or stacked is a provider decision based on your goals and starting point.
What are ipamorelin's most common side effects?
Studies and clinical observations report temporary headache, flushing, and injection-site discomfort as the most common side effects. Water retention can occur. Elevated cortisol and prolactin — common with older GHRPs — are less commonly reported with ipamorelin due to its receptor selectivity. Serious adverse events are uncommon when used at appropriate doses under medical supervision.
Should I inject ipamorelin before or after eating?
Before eating, or at least 90 minutes after a meal. Food — especially carbohydrates and fat — raises insulin and reduces the GH pulse triggered by ipamorelin. Fasted injections or bedtime injections (a few hours after your last meal) align best with how GH release works. Your provider will advise on specific timing for your protocol.
Does ipamorelin require ongoing labs?
Most providers recommend baseline IGF-1 before starting and a follow-up at 6–8 weeks to assess GH axis response. Ongoing monitoring frequency depends on your protocol length and any adjustments made along the way. Never skip provider follow-up — labs catch both under-response and over-response before they become clinical issues.
TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service.
Start your private evaluation at TelosRX.